Eribulin Mesylate Injection 0.5 mg/mL – Reliable Oncology Medicine for Global Healthcare Markets
Cancer care requires access to high-quality oncology medicines manufactured under stringent quality standards. Eribulin Mesylate Injection 0.5 mg/mL is an intravenous chemotherapy medicine indicated in many jurisdictions for certain patients with metastatic breast cancer and unresectable or metastatic liposarcoma, as determined by approved local prescribing information and oncology specialists.
Cordium Pharmaceuticals Pvt Ltd is an Indian pharmaceutical manufacturer committed to supplying quality oncology injectables to healthcare institutions, pharmaceutical distributors, and licensed importers worldwide, subject to each country's regulatory requirements.
What is Eribulin Mesylate Injection?
Eribulin Mesylate Injection is a microtubule dynamics inhibitor used in oncology treatment. It works by disrupting cancer cell division, helping inhibit tumor growth. The medicine is administered intravenously by qualified healthcare professionals in hospitals and specialized oncology centers.
Product Specifications
- Product Name: Eribulin Mesylate Injection
- Strength: 0.5 mg/mL
- Dosage Form: Sterile Injectable
- Route of Administration: Intravenous (IV)
- Category: Oncology Injectable
- Manufacturer: Cordium Pharmaceuticals Pvt Ltd
- Origin: India
Therapeutic Applications
Eribulin Mesylate Injection may be prescribed by oncologists for approved indications such as:
- Metastatic Breast Cancer
- Unresectable Liposarcoma
- Advanced Soft Tissue Sarcoma (where approved)
Treatment should always follow local regulatory approvals, prescribing information, and physician guidance.
Trusted Supply for Hospitals, Pharma Distributors & Licensed Buyers
Cordium Pharmaceuticals Pvt Ltd supports healthcare organizations and licensed pharmaceutical partners seeking dependable oncology medicine supply.
Hospitals
We work with hospitals and oncology centers looking for reliable pharmaceutical manufacturers capable of supporting institutional procurement.
Pharma Distributors
We collaborate with pharmaceutical distributors, wholesalers, and importers interested in expanding their oncology portfolios while complying with local regulations.
Personal Import
Where permitted under applicable laws, eligible patients may explore personal import options through authorized healthcare providers, licensed pharmacies, or import channels. Personal import regulations vary by country and should always be verified before purchase or shipment.
Export Markets We Support
We serve international pharmaceutical partners in markets including:
United States
Supporting licensed pharmaceutical buyers in major healthcare hubs such as:
- Washington
- New York
- California
United Kingdom
Serving pharmaceutical partners across:
- London
- Manchester
- Birmingham
United Arab Emirates
Supporting distributors and healthcare organizations in:
- Dubai
- Abu Dhabi
South Africa
Serving healthcare institutions and licensed distributors in:
- Johannesburg
- Cape Town
- Durban
All supply is subject to country-specific registration, import, and regulatory requirements.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Healthcare providers and pharmaceutical partners value manufacturers that emphasize quality, reliability, and responsive service. Cordium Pharmaceuticals Pvt Ltd focuses on:
- Quality-focused manufacturing practices
- Oncology product expertise
- Reliable international supply chain
- Professional documentation support
- Export-oriented operations
- Competitive pricing
- Customer-focused service
- Timely order fulfillment
- Consistent product availability (subject to production schedules)
- Long-term business partnerships
Benefits of Partnering with Cordium Pharmaceuticals
- Trusted pharmaceutical manufacturing from India
- Support for hospitals and institutional procurement
- Collaboration with licensed distributors and wholesalers
- Export documentation assistance
- Responsive customer support
- Scalable supply capabilities for qualified buyers
Frequently Asked Questions (FAQs)
What is Eribulin Mesylate Injection used for?
Eribulin Mesylate Injection is used in oncology for certain patients with metastatic breast cancer and unresectable or metastatic liposarcoma, according to approved prescribing information in applicable markets.
Who can purchase Eribulin Mesylate Injection?
Hospitals, oncology centers, licensed pharmaceutical distributors, wholesalers, and authorized importers may procure the product in accordance with local regulations. Patients should obtain medicines only through authorized healthcare providers and legal supply channels.
Can Cordium Pharmaceuticals export internationally?
Cordium Pharmaceuticals works with international pharmaceutical partners and licensed importers, subject to applicable export and destination-country regulatory requirements.
Is personal import available?
Personal import rules differ by country. Patients should consult their physician, local customs authority, and applicable regulations before arranging any import.
What packaging options are available?
Packaging configurations may vary. Please contact Cordium Pharmaceuticals for current commercial packaging information.
Does Cordium support hospitals and institutional tenders?
Cordium can engage with qualified hospitals, institutional buyers, and pharmaceutical procurement organizations regarding commercial supply opportunities, subject to applicable requirements.
Why choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals is committed to quality-focused manufacturing, dependable supply, export support, and responsive service for healthcare institutions and licensed pharmaceutical partners.
Partner with Cordium Pharmaceuticals Pvt Ltd
If you are a hospital, oncology center, licensed pharmaceutical distributor, wholesaler, or authorized importer seeking a dependable supplier of Eribulin Mesylate Injection 0.5 mg/mL, Cordium Pharmaceuticals Pvt Ltd welcomes inquiries for international business partnerships, subject to local regulatory compliance.